Top 10 Companies in the (R)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione Market (2026): Market Leaders Powering Global Innovation

MARKET INSIGHTS

The global (R)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.4% during the forecast period.

(R)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione is a chiral epoxide derivative of isoindoline-1,3-dione, a compound characterized by its reactive oxirane ring attached to the isoindoline scaffold via a methylene bridge. It carries the CAS number 161596-47-0 and serves as a valuable chiral building block and pharmaceutical intermediate. The compound’s enantioselective properties make it particularly suited for asymmetric synthesis applications in the development of active pharmaceutical ingredients (APIs), specialty chemicals, and fine chemical research workflows.

The market is steadily gaining traction due to rising demand for enantiomerically pure intermediates in drug discovery and development pipelines, particularly within the pharmaceutical and agrochemical sectors. Furthermore, increased investment in chiral chemistry and the growing focus on stereoselective synthesis methodologies are reinforcing demand. Key suppliers and specialty chemical manufacturers operating in this space include TCI Chemicals, Sigma-Aldrich (Merck KGaA), and Combi-Blocks, among others offering this compound across research and commercial-scale quantities.

(R)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione Market – View in Detailed Research Report

🔟 1. Capot Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Pharmaceutical‑grade (R)-2-(oxiran-2-ylmethyl)isoindoline‑1,3‑dione, custom synthesis, API intermediates

Capot Chemical is a leading fine‑chemical manufacturer with advanced chiral resolution technologies and cGMP production lines. Their high‑purity (R)-enantiomer is widely used in antiviral and oncology drug development, supporting major pharma clients worldwide.

Sustainability & Growth Initiatives:

• Investment in green epoxidation processes reducing solvent use by 25%
• Expansion of production capacity by 30% to meet rising demand
• Partnerships with CDMOs for rapid scale‑up of custom synthesis

9️⃣ 2. Shanghai Trustin Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: High‑purity (R)-enantiomer, bulk supply, API intermediates

Shanghai Trustin combines vertical integration in epoxide synthesis with rigorous quality control, delivering consistent supply to pharmaceutical manufacturers and research institutions.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient reactors cutting CO₂ emissions by 18%
• Adoption of closed‑loop solvent recycling systems
• Collaboration with universities on chiral catalyst development

8️⃣ 3. Finetech Industry Limited

Headquarters: Shenzhen, China
Key Offering: Industrial‑grade (R)-2-(oxiran-2-ylmethyl)isoindoline‑1,3‑dione, polymer additives

Finetech supplies high‑quality epoxide intermediates for specialty chemical applications, enabling precise stereocontrol in polymer chemistry and fine‑chemical research.

Sustainability & Growth Initiatives:

• Launch of biocatalytic epoxidation line reducing hazardous waste
• Investment in AI‑driven process optimization for yield enhancement
• Strategic partnership with a leading CDMO to expand market reach

7️⃣ 4. BLDpharm

Headquarters: Guangzhou, China
Key Offering: Custom formulation services, research‑grade epoxide, API intermediates

BLDpharm specializes in tailor‑made synthesis solutions, providing rapid turnaround for contract development and manufacturing organizations.

Sustainability & Growth Initiatives:

• Deployment of green chemistry protocols cutting solvent consumption by 22%
• Expansion of R&D facilities focused on chiral catalysis
• Development of an online platform for real‑time order tracking and quality reporting

6️⃣ 5. Hairui Fine Chemical Co., Ltd.

Headquarters: Hangzhou, China
Key Offering: Research‑grade (R)-enantiomer, specialty chemical intermediates

Hairui provides high‑purity epoxide building blocks for academic research and pharmaceutical development, emphasizing strict compliance with international standards.

Sustainability & Growth Initiatives:

• Implementation of renewable energy sources powering production lines
• Certification of ISO 14001 environmental management system
• Collaboration with global pharma to develop green synthesis routes

5️⃣ 6. Enamine Ltd.

Headquarters: Kyiv, Ukraine
Key Offering: Research‑grade (R)-2-(oxiran-2-ylmethyl)isoindoline‑1,3‑dione, chiral building blocks

Enamine offers a comprehensive catalog of chiral reagents, supporting academic and industrial research in asymmetric synthesis.

Sustainability & Growth Initiatives:

• Adoption of low‑toxicity solvents in synthesis protocols
• Participation in EU green chemistry initiatives
• Development of an open‑access database for chiral reagents

4️⃣ 7. Ambeed Inc.

Headquarters: Toronto, Canada
Key Offering: High‑purity (R)-enantiomer, bulk supply, API intermediates

Ambeed delivers premium quality epoxide intermediates to pharmaceutical manufacturers, emphasizing cGMP compliance and traceability.

Sustainability & Growth Initiatives:

• Implementation of a carbon‑neutral production plan
• Use of biodegradable packaging materials
• Strategic alliance with a leading CDMO for joint product development

3️⃣ 8. Toronto Research Chemicals (TRC)

Headquarters: Toronto, Canada
Key Offering: Research‑grade epoxide, chiral building blocks, API intermediates

TRC provides high‑purity (R)-enantiomers for research and development, supporting a wide range of pharmaceutical and agrochemical projects.

Sustainability & Growth Initiatives:

• Investment in renewable energy for manufacturing facilities
• Development of a closed‑loop waste management system
• Collaboration with universities on green catalyst research

2️⃣ 9. Biosynth

Headquarters: Zurich, Switzerland
Key Offering: High‑purity (R)-enantiomer, API intermediates, custom synthesis

Biosynth offers premium epoxide intermediates with stringent quality controls, catering to the European pharma market.

Sustainability & Growth Initiatives:

• Use of green solvents and energy‑efficient processes
• Participation in REACH compliance programs
• Partnerships with CDMOs to expand global distribution

1️⃣ 10. Apollo Scientific Ltd.

Headquarters: London, United Kingdom
Key Offering: Research‑grade epoxide, chiral building blocks, API intermediates

Apollo Scientific delivers high‑purity (R)-enantiomers to pharmaceutical and fine‑chemical sectors, emphasizing rapid delivery and technical support.

Sustainability & Growth Initiatives:

• Adoption of green chemistry principles across production
• Implementation of digital traceability for supply chain transparency
• Collaboration with industry partners on sustainable synthesis projects

Download FREE Sample Report

Get Full Report

🌍 Outlook: The Future of (R)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione Market

The market is poised for sustained growth driven by expanding pharmaceutical R&D pipelines, increasing demand for enantiomerically pure intermediates, and a global shift toward green chemistry. Technological advances in chiral resolution and biocatalytic synthesis are expected to lower costs and improve scalability, positioning the market for continued expansion through 2034.

📈 Key Trends Shaping the Market

• Expansion in Asia‑Pacific manufacturing capacity, capturing >45% of market share by 2028.
• Regulatory push for stricter chiral purity standards by FDA and EMA.
• Adoption of green epoxidation processes reducing solvent and energy consumption.
• Digitalization of supply chain with real‑time inventory and quality tracking.
• Increased collaboration between CDMOs and academic institutions for rapid innovation.